Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

Sign up to stay up to date with the stocks you care about

Add FARON PHARMACEUTICALS OY to Feed

FARON PHARMACEUTICALS OY

Latest news & discussion for FARON PHARMACEUTICALS OY:

26

1

FARON PHARMACEUTICALS OY Results of Faron Pharmaceuticals Oy's Annual General Meeting and Change of Directors

Posted by AssetRoom | 6 months ago | 0 comments

27

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Announces Placing of Newly Issued Treasury Shares to Raise EUR 4.8 Million

Posted by AssetRoom | 6 months ago | 0 comments

28

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Issues Warrants to IPF and Provides Funding Update

Posted by AssetRoom | 6 months ago | 0 comments

29

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Annual Report 2023 Summary

Posted by AssetRoom | 6 months ago | 0 comments

30

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Announces Positive Data from BEXMAB Study

Posted by AssetRoom | 7 months ago | 0 comments

31

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy to Host Webcast for BEXMAB Study Update

Posted by AssetRoom | 7 months ago | 0 comments

32

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Annual General Meeting 2024 Notice and Agenda

Posted by AssetRoom | 7 months ago | 0 comments

33

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Financial Statement Release Summary

Posted by AssetRoom | 7 months ago | 0 comments

34

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Secures EUR 3.2 Million in Convertible Loans for Short-Term Financing

Posted by AssetRoom | 7 months ago | 0 comments

35

1

FARON PHARMACEUTICALS OY Update to Faron Pharmaceuticals Oy's Financial Calendar for 2024

Posted by AssetRoom | 7 months ago | 0 comments

36

1

FARON PHARMACEUTICALS OY Update to Faron Pharmaceuticals Oy's Financial Calendar for 2024

Posted by AssetRoom | 7 months ago | 0 comments

37

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Negotiates Financing Options and Considers Rights Issue

Posted by AssetRoom | 8 months ago | 0 comments

38

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy in Breach of Funding Agreement

Posted by AssetRoom | 8 months ago | 0 comments

39

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Announces Exercise of Options and Details BEXMAB Study

Posted by AssetRoom | 8 months ago | 0 comments

40

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Announces Detailed Analysis of BEXMAB Data

Posted by AssetRoom | 8 months ago | 0 comments

41

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Announces Exercise of Options and Issue of Equity

Posted by AssetRoom | 9 months ago | 0 comments

42

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy Announces First Patient Dosed with Bexmarilimab in Phase 2 of BEXMAB Trial

Posted by AssetRoom | 9 months ago | 0 comments

43

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Oy to Present at J.P. Morgan Healthcare Conference

Posted by AssetRoom | 9 months ago | 0 comments

44

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Announces Financial Calendar for 2024

Posted by AssetRoom | 10 months ago | 0 comments

45

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Presents Positive Phase 1 Data on BEXMAB in Myeloid Malignancies Trial at ASH Annual Meeting

Posted by AssetRoom | 10 months ago | 0 comments

46

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Announces Positive Results from Phase 1/2 Trial of Bexmarilimab in Solid Tumors

Posted by AssetRoom | 10 months ago | 0 comments

47

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Grants Options for Ordinary Shares Under Share Option Plan 2019

Posted by AssetRoom | 10 months ago | 0 comments

48

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Initiates Phase 2 Study of Bexmarilimab in HMA-Failed MDS Patients

Posted by AssetRoom | 11 months ago | 0 comments

49

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals Grants Warrants to IPF Partners as Part of Funding Agreement

Posted by AssetRoom | 11 months ago | 0 comments

50

1

FARON PHARMACEUTICALS OY Faron Pharmaceuticals to Present Phase 1/2 Data on Bexmarilimab in Myeloid Malignancies at ASH Annual Meeting

Posted by AssetRoom | 11 months ago | 0 comments